Minimally Invasive Therapeutics
Improving patient compliance requires drug delivery systems that are both effective and less invasive. Our efforts focus on biomaterial-based delivery systems that facilitate the precise transport of therapeutic agents through transdermal, and oral routes. These advanced systems leverage materials science and molecular engineering to improve bioavailability, enhance drug stability, and enable controlled or sustained release, thereby ensuring optimal therapeutic outcomes.
